Skip to main content
OpenTrials
Completed

NCT Number: NCT02170883

EmPhAsIS: Empowering Pharmacists in Asthma Management Through Interactive SMS

Between 8% and 12% of Canadians suffer from asthma. Although there are effective and inexpensive treatments, adherence to asthma treatment is amongst the lowest for all chronic diseases.The purpose of this study is to determine whether enhancing the role of community pharmacists in asthma management using interactive short messaging service (SMS) with asthma patients is a cost-effective model that will improve adherence to inhaled corticosteroid medications compared to usual care.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Asthma Bronchial Diseases Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Lung Diseases Lung Diseases, Obstructive Respiratory Hypersensitivity Respiratory Tract Diseases

Age range

14 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

UBC

Vancouver, British Columbia, V6T 1Z3, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • individuals who fill a (incident or prevalent) prescription for inhaled corticosteroids (either monotherapy or in combination inhaler with long-acting beta-agonists) who have been diagnosed by a doctor as having asthma
  • possessing a cell-phone with ability to send/receive text messages
  • residing in British Columbia (BC), Canada and planning to reside in BC for the next 12 months
  • registered with the medical services plan (MSP, the provincial insure of medically-required services) in the past 12 months, and planning to remain registered for the next 12 months
  • designated pharmacy being the main drugstore for patient
  • not participating in another interventional study
  • consent to participate in the study.

Exclusion criteria

  • Unable to communicate in English
  • Under 14 years of age

Treatment and study plan

Interactive SMS

Other

Usual Care

Other

Primary outcomes

  1. Adherence to inhaled corticosteroid medication

    Time frame: 12 months

    Adherence assessed by medication possession ratio

Secondary outcomes

  1. Asthma control

    Time frame: Baseline

    Asthma control assessed by the Asthma Control Test

  2. Asthma control

    Time frame: 6 months

    Asthma control assessed by the Asthma Control Test

  3. Asthma control

    Time frame: 12 months

    Asthma control assessed by the Asthma Control Test

  4. Quality of life measured by the Asthma Quality of Life Questionnaire

    Time frame: Baseline

    Quality of life measured by the Asthma Quality of Life Questionnaire

  5. Quality of life measured by the Asthma Quality of Life Questionnaire

    Time frame: 3 months

    Quality of life measured by the Asthma Quality of Life Questionnaire

  6. Quality of life measured by the Asthma Quality of Life Questionnaire

    Time frame: 12 months

    Quality of life measured by the Asthma Quality of Life Questionnaire

  7. Health care resource utilization

    Time frame: 12 months

    Asthma-related hospital admissions and emergency department visits

  8. Use of reliever medication for acute asthma attacks

    Time frame: 12 months

    Use of reliever medication for acute asthma attacks

Sponsors and collaborators

Lead sponsor

University of British Columbia

Other

Collaborators

  • Canadian Institutes of Health Research (CIHR)
  • College of Pharmacists of British Columbia
  • WelTel

Registry information

Important dates

Study start
2015
Primary completion
2019
Study completion
2019
First posted
Jun 23, 2014
Registry last updated
Dec 10, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.